Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Ipca Laboratories Ltd. Capital/Financing Update 2021

Feb 1, 2021

61700_rns_2021-02-01_74152f6a-1ec8-422d-8022-4876c74e1e84.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

THRU ONLINE FILING

February 1,2021

BSE Ltd. Phiroze Jeejeebhoy Towers Dalal Street Mumbai 400 023 Scrip Code - 524494

National Stock Exchange India Limited, Exchange Plaza, C-1, Block-G, Bandra Kurla Complex, Bandra - (East). Mumbai-400051. Scrip Code: IPCALAB

Sub: Credit Rating for bank facilities

This is to inform you that CARE Ratings has reviewed and reaffirmed the following ratings to Company's long term / short term bank facilities:

nk facilities:
Facilites Amount
Rating RatingAction
Long Term / Short (Rs. Crore)1140.00 CARE AA; Stable / Care A 1+ Reaffirmed
Term Bank Facilites (Double A; Outlook:Stable/ A One
Plus)
Total 1140.00

This is for your information.

Thanking you

Yours faithfully For Ipca Laboratories Limited

~ Harish P. Kamath .' Corporate Counsel & Company Secretary

Ipea Laboratories Ltd. www.ipca.com

125, Kandivli Industrial Estate, CTS No. 328, Kandivli (West), Mumbai 400 067 (Maharashtra), India I T: +91 2262105000 F:+91 2262105005 Regd. Office: 48, Kandivli Industrial Estate, Kandivli (West), Mumbai 400 067 (Maharashtra), India I T: +91 2266474444 E:[email protected] ON: L24239MH1949PLC007837